Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists Guidelines: A Report from the Association for Molecular Pathology (vol 25, pg 69, 2023)

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 04期
关键词：
D O I：
10.1016/j.jmoldx.2023.01.007
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [21] Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement Summary of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update
    Kalemkerian, Gregory P.
    Narula, Navneet
    Kennedy, Erin B.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (05) : 323 - +
  • [22] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
    Bartley, Angela N.
    Washington, Mary Kay
    Ventura, Christina B.
    Ismaila, Nofisat
    Colasacco, Carol
    Benson, Al B., III
    Carrato, Alfredo
    Gulley, Margaret L.
    Jain, Dhanpat
    Kakar, Sanjay
    Mackay, Helen J.
    Streutker, Catherine
    Tang, Laura
    Troxell, Megan
    Ajani, Jaffer A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (06) : 647 - 669
  • [23] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
    Bartley, Angela N.
    Washington, Mary Kay
    Ismaila, Nofisat
    Ajani, Jaffer A.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (01) : 53 - +
  • [24] Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline
    Leighl, Natasha B.
    Rekhtman, Natasha
    Biermann, William A.
    Huang, James
    Mino-Kenudson, Mari
    Ramalingam, Suresh S.
    West, Howard
    Whitlock, Sara
    Somerfield, Mark R.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (32) : 3673 - +
  • [25] Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline
    Rekhtman, Natasha
    Leighl, Natasha B.
    Somerfield, Mark R.
    JOURNAL OF ONCOLOGY PRACTICE, 2015, 11 (02) : 135 - U502
  • [26] Recommendations for Clinical CYP2C9 Genotyping Allele Selection A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists
    Pratt, Victoria M.
    Cavallari, Larisa H.
    Del Tredici, Andria L.
    Hachad, Houda
    Ji, Yuan
    Moyer, Ann M.
    Scott, Stuart A.
    Whirl-Carrillo, Michelle
    Weck, Karen E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (05): : 746 - 755
  • [27] Recommendations for Cell-Free DNA Assay Validations A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists
    Lockwood, Christina M.
    Borsu, Laetitia
    Cankovic, Milena
    Earle, Jonathan S. L.
    Gocke, Christopher D.
    Hameed, Meera
    Jordan, Danielle
    Lopategui, Jean R.
    Pullambhatla, Mrudula
    Reuther, Jacquelyn
    Rumilla, Kandelaria M.
    Tafe, Laura J.
    Temple-Smolkin, Robyn L.
    Terraf, Panieh
    Tsimberidou, Apostolia M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (12): : 876 - 897
  • [28] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (vol 137, pg 828, 2013)
    Lindeman, N., I
    Cagle, P. T.
    Beasley, M. B.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (06) : 1174 - 1174
  • [29] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (vol 8, pg 823, 2013)
    Lindeman, N., I
    Cagle, P. T.
    Beasley, M. B.
    Chitale, D. A.
    Dacic, S.
    Giaccone, G.
    Jenkins, R. B.
    Kwiatkowski, D. J.
    Saldivar, J. S.
    Squire, J.
    Thunnissen, E.
    Ladanyi, M.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (10) : 1343 - 1343
  • [30] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
    Lindeman, Neal I.
    Cagle, Philip T.
    Beasley, Mary Beth
    Chitale, Dhananjay Arun
    Dacic, Sanja
    Giaccone, Giuseppe
    Jenkins, Robert Brian
    Kwiatkowski, David J.
    Saldivar, Juan-Sebastian
    Squire, Jeremy
    Thunnissen, Erik
    Ladanyi, Marc
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 823 - 859
12345